NCT00532168View on ClinicalTrials.gov

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

PHASE4CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

HIV Infections

Interventions

DRUG

tenofovir + emtricitabine + efavirenz

tenofovir + emtricitabine + efavirenz, approved dose, oral route, QD

DRUG

tenofovir + emtricitabine + lopinavir-ritonavir

tenofovir + emtricitabine (QD) + lopinavir-ritonavir (BID), oral route, approved dose

DRUG

tenofovir + emtricitabine + atazanavir-ritonavir

tenofovir + emtricitabine + atazanavir + ritonavir (100 mg), oral route, approved dose, QD

Trial Locations (1)

08036

Hospital Clinic, Barcelona

All Listed Sponsors

lead

Juan A. Arnaiz

OTHER

NCT00532168 - Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl | Biotech Hunter | Biotech Hunter